Detalhe da pesquisa
1.
Unintended drug exposure during pregnancy in clinical trials - a survey in early drug development.
Int J Clin Pharmacol Ther
; 59(1): 26-30, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33141016
2.
Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17ß-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
Eur J Contracept Reprod Health Care
; 23(4): 245-254, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30203681
3.
A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
Hum Reprod
; 32(8): 1639-1647, 2017 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28591833
4.
Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.
Eur J Contracept Reprod Health Care
; 20(6): 463-75, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26212489
5.
Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.
Eur J Contracept Reprod Health Care
; 20(6): 476-89, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26394847
6.
Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study.
J Fam Plann Reprod Health Care
; 38(2): 73-83, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22454003
7.
Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study.
J Fam Plann Reprod Health Care
; 38(2): 84-93, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22454004
8.
Effect on ovarian activity and ovulation inhibition of different oral dosages of levonorgestrel.
Contraception
; 110: 6-15, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123981
9.
Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
Contraception
; 103(4): 213-221, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428907
10.
Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function.
Contraception
; 103(6): 386-393, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689786
11.
Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women.
Gynecol Endocrinol
; 26(3): 152-60, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19757237
12.
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol.
Eur J Contracept Reprod Health Care
; 15(5): 314-25, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20695770
13.
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
Contraception
; 102(6): 396-402, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956694
14.
The effects on ovarian activity of delaying versus immediately restarting combined oral contraception after missing three pills and taking ulipristal acetate 30 mg.
Contraception
; 102(3): 145-151, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32474062
15.
Ovulation inhibition with a new vaginal ring containing trimegestone.
Contraception
; 102(4): 237-242, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32569678
16.
A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17ß-estradiol in the treatment of women with primary dysmenorrhea.
Contraception
; 99(2): 125-130, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30439359
17.
Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial.
Menopause
; 15(2): 248-55, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17693902
18.
Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.
Contraception
; 78(1): 16-25, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18555813
19.
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
Contraception
; 78(3): 218-25, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18692612
20.
Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol.
Contraception
; 95(2): 140-147, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27593335